Clinical Lab Products
  • Diagnostic Technologies
    • Anatomic Pathology
    • Clinical Chemistry
    • Digital Pathology
    • Flow Cytometry
    • Hematology & Serology
    • Immunoassay
    • Mass Spectrometry
    • Microbiology
    • Molecular Diagnostics
    • Point-of-Care
    • Urinalysis & Toxicology
  • Lab Essentials
    • Biochemicals & Chemical Reagents
    • Information Technology
    • Lab Automation
    • Lab Equipment
    • Lab Safety
    • Labware & Consumables
    • Quality Systems
  • Disease States
    • Allergy & Autoimmune
    • Cancer
    • Cardiovascular
    • Cerebrovascular
    • Dementias & Alzheimer’s
    • Diabetes & Metabolic Diseases
    • Infectious Diseases
    • Kidney Disease
    • Respiratory Disease
    • Sepsis
    • Womens Health
  • Lab Management
    • Accreditation
    • Company News
    • Compliance
    • Proficiency Testing
    • Resource Center
  • Resources
    • Podcasts
    • Webcasts
    • White Papers
    • Videos
  • Edition Archive

Select Page

CDC Reports Early Start to 2012-2013 Flu Season

Dec 4, 2012 | Miscellaneous |

CDC Reports Early Start to 2012-2013 Flu Season
3D Influenza black no key pieslice lrgThe Centers for Disease Control and Prevention (CDC) reports that flu cases are on the rise around the United States.
 
CDC Director Thomas Frieden called this start of the 2012-2013 flu season “the earliest regular flu season in nearly a decade,” adding, “This could be a bad flu year.”
 
The most recent CDC FluView surveillance shows high levels of influenza-like illness activity in five US states:  Tennessee, Alabama, Louisiana, Mississippi, and Texas. Frieden added that he expects it is “just a matter of time” before activity increases in other states.
 
In the past, flu seasons have been more severe when the influenza A virus subtype H3N2 is in wide circulation. Melinda Wharton, acting director of CDC’s National Center for Immunization and Respiratory Diseases, reported that so far this year there has been a predominance of this influenza strain.
 
“This year’s strains look to be a great match for the influenza vaccine,” Frieden adds. Based on early testing of flu specimens, the composition of the 2012-2013 seasonal influenza vaccine is a 98% match for the flu viruses that are circulating in the population. “The vaccine is still the best tool to protect against the flu,” he said.
 
CDC says that flu vaccination rates have been increasing over the past few years, especially among vulnerable populations such as pregnant women, children, and health care workers. Newly-released mid-season influenza immunization rates indicate that between 80% to 90% of pharmacists, physicians, and nurses have received the flu vaccine this year. 
 
CDC officials advise that there is plenty of influenza vaccine still available for those who have not been vaccinated yet, and that it’s not too late to get the seasonal flu shot.
 
Click here for more information about CDC’s seasonal influenza surveillance.
 
[The above image provides a 3-D graphical representation of the biology and structure of a generic influenza virus, and is not specific to the 2009 H1N1 virus.
 
[Source: CDC]

Share:

Rate:

PreviousNew Data Demonstrate Efficacy of OncoHealth’s HPV E6/E7 Assays
NextRandox Offers New Solution to Mid-Volume Clinical Chemistry Testing

Related Posts

Microbiology textbook

Microbiology textbook

July 10, 2000

New FOB Test Offers Convenience, Higher Reimbursement

New FOB Test Offers Convenience, Higher Reimbursement

May 4, 2005

Ultra sensitive C-reactive protein

Ultra sensitive C-reactive protein

August 6, 2000

Quest Diagnostics: End of H1N1 Second Wave in Sight in the US

Quest Diagnostics: End of H1N1 Second Wave in Sight in the US

December 22, 2009

Recent Posts

  • Are AI-Powered Neurodiagnostic Solutions the New Frontier in Alzheimer’s Prevention?
  • VieCure Expands Precision Oncology Ecosystem Through Partnership with Guardant Health
  • SPT Labtech and Semarion Collaborate on Automated Workflows
  • Wristband Sensor Provides All-in-One Diabetes and Cardiovascular Monitoring
  • Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients

Clinical Lab Products

7300 W 110th St – Floor 7
Overland Park, KS 66210
(913) 955-2600

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Press Releases

Key Resources

Podcasts

Webinars

White Papers

Videos

Helpful Links

Media Solutions Kit

Subscribe Now

Contact Us

Submit an Article

  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2024 MEDQOR LLC. All Rights Reserved

✖